StockNews.com began coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research report report published on Wednesday morning. The brokerage issued a hold rating on the stock.
China Pharma Price Performance
Shares of CPHI opened at $0.20 on Wednesday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.24 and a current ratio of 0.84. The business has a fifty day moving average of $0.23 and a 200 day moving average of $0.25. China Pharma has a 52-week low of $0.17 and a 52-week high of $1.16.
China Pharma (NYSE:CPHI – Get Free Report) last issued its quarterly earnings results on Wednesday, August 14th. The company reported ($0.09) EPS for the quarter. The firm had revenue of $0.93 million for the quarter. China Pharma had a negative net margin of 70.47% and a negative return on equity of 60.19%.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Stories
- Five stocks we like better than China Pharma
- What is the Dogs of the Dow Strategy? Overview and Examples
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- How to Evaluate a Stock Before Buying
- MarketBeat Week in Review – 11/4 – 11/8
- What is the S&P/TSX Index?
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
